As bacteria continues to become more resistant to traditional antibiotics, the need to combat antibiotic resistance has never been more important. One approach to combating ever-evolving bacteria comes in the form of the CRISPR pill. Scientists are now looking at the CRISPR pill as a means of ultra-precise antimicrobial treatment. In short, the CRISPR pill could be used to specifically kill a bacteria of choice.
The CRISPR pill works by storing memories of viral DNA in its genomes as "Clustered Regularly Interspaced Short Palindromic Repeats," or CRISPRS. The memory saved by the CRISPR pill is then combined with an enzyme known as Cas to identify and destroy the genes of invading bacteria.
Probiotic CRISPR technology is still in its infancy and has yet to begin trials on animals. However, early lab studies and research has shown the effectiveness of CRISPR pills in efficiently killing skin bacteria.
What's Driving This Trend
- Antibiotic Resistance
- The need to combat antibiotics resistance drives the development of hyper-targeted antimicrobial pills.
- CRISPR Technology
- The CRISPR pill represents a breakthrough in ultra-precise antimicrobial treatment.
- Probiotic Innovation
- Research on probiotic CRISPR technology opens up new possibilities for efficient bacteria eradication.
Who This Affects Most
- Pharmaceuticals
- Pharmaceutical companies can explore the potential of developing hyper-targeted antimicrobial pills to address antibiotic resistance.
- Biotechnology
- Biotech companies can further advance CRISPR technology for ultra-precise antimicrobial treatment.
- Healthcare
- Healthcare providers can benefit from implementing probiotic CRISPR technology for efficient bacteria eradication.
